Clinical trial
Development of a Genome-based Platform for Personalized Treatment in Locally Advanced Rectal Cancer Patients
NCT04738214 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Genome-based Platform for Personalized Treatment in Locally Advanced Rectal Cancer Patients
- Lead sponsor
- Yonsei University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 28, 2021
- Completion date
- January 18, 2025
- Enrollment
- 39 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced rectal cancer